Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.24%
1,103.05
+2.67
+0.24%
1,100.381,096.191,112.971,094.08
SIXC
Communications
SIXC
Communications
SIXC
+0.19%
622.42
+1.21
+0.19%
621.21621.21624.47618.56
SIXE
Energy
SIXE
Energy
SIXE
-2.87%
1,157.44
-34.22
-2.87%
1,191.661,158.281,160.761,124.17
SIXI
Industrials
SIXI
Industrials
SIXI
+1.82%
1,750.30
+31.25
+1.82%
1,719.051,729.911,766.941,729.91
SIXM
Financials
SIXM
Financials
SIXM
+0.75%
646.61
+4.84
+0.75%
641.77643.39653.21643.39
SIXR
Staples
SIXR
Staples
SIXR
+1.26%
833.78
+10.40
+1.26%
823.38822.99834.38820.61
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.54%
218.49
+3.31
+1.54%
215.18215.18218.76215.18
SIXT
Technology
SIXT
Technology
SIXT
+1.50%
3,109.02
+45.83
+1.50%
3,063.193,096.933,118.043,093.29
SIXU
Utilities
SIXU
Utilities
SIXU
-0.42%
935.18
-3.92
-0.42%
939.10937.35937.41924.95
SIXV
Health care
SIXV
Health care
SIXV
+1.45%
1,503.60
+21.56
+1.45%
1,482.041,485.591,506.801,485.59
SIXY
Discretionary
SIXY
Discretionary
SIXY
+2.36%
2,435.30
+56.09
+2.36%
2,379.212,409.512,463.802,409.51
Cell Biotech Co Ltd
₩16,380.00
-1.03%
(-170.00) 1D
Apr 17, 3:30:19 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 049960...
Open
₩16,710
High
₩16,710
Low
₩16,050
Mkt. cap
153.97B
Avg. vol.
18.80K
Volume
19.41K
Dividend
3.66%
Quarterly dividend
₩150
Ex dividend date
Dec 27, 2023
P/E ratio
11.07
52-wk high
₩16,710
52-wk low
₩11,350
EPS
₩1,479
Shares outstanding
9.40M
No. of employees
106
News stories
From sources across the web
About Cell Biotech Co Ltd
CEOMyung-jun Chung
Employees106
Founded1995
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
11.23B
11.91B
15.36B
14.63B
Cost of goods sold
3.29B
3.08B
4.42B
3.98B
Cost of revenue
3.29B
3.08B
4.42B
3.98B
Research and development expenses
1.02B
1.07B
846.82M
941.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.87B
5.81B
7.22B
6.03B
Operating expense
6.58B
7.55B
8.72B
7.60B
Total operating expenses
9.87B
10.63B
13.14B
11.58B
Operating income
1.36B
1.28B
2.22B
3.05B
Other non operating income
57.66M
54.34M
46.11M
61.38M
EBT including unusual items
2.41B
65.93M
4.10B
4.68B
EBT excluding unusual items
2.09B
-282.81M
4.17B
4.52B
Income tax expense
337.77M
-147.53M
648.29M
290.10M
Effective tax rate
14.03%
-223.76%
15.82%
6.19%
Other operating expenses
70.26M
55.81M
49.84M
40.45M
Net income
2.07B
213.46M
3.45B
4.39B
Net profit margin
18.43%
1.79%
22.46%
30.02%
Earnings per share
-
-
-
-
Interest and investment income
695.43M
701.58M
689.61M
691.29M
Interest expense
-10.64M
-8.90M
-7.37M
-5.68M
Net interest expenses
684.79M
692.68M
682.24M
685.61M
Depreciation and amortization charges
536.06M
538.85M
537.83M
544.32M
EBITDA
2.28B
2.18B
3.11B
3.95B
Gain or loss from assets sale
-30.35M
-32.57M
2.00K
170.99M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more